ClinicalTrials.Veeva

Menu

Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring

MiMedx logo

MiMedx

Status

Completed

Conditions

Scarring

Treatments

Other: dHACM
Procedure: Craniectomy

Study type

Interventional

Funder types

Industry

Identifiers

NCT02033824
AFCRAN001

Details and patient eligibility

About

The purpose of this study is to evaluate the effectiveness of dHACM in reducing scar tissue formation in craniectomy patients as well as facilitating reoperation and repair. Specifically this study compares craniectomy without dHACM application to craniectomy with placement of dHACM between the galea and dura over dural suture line and/or exposed parenchyma.

Enrollment

7 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults ages 18 or older.
  • Diagnosed with closed head trauma or cerebral infarction where decompressive craniectomy with durotomy is performed.
  • Willingness to comply with study procedures.
  • The patient's or legally authorized representative's (LAR's) ability to give full written consent.

Exclusion criteria

  • Prior surgery at the site
  • Participation in another ongoing trial
  • Open cranial wounds
  • Site exhibits clinical signs and symptoms of local infection.
  • Current diagnosis of cancer at the site
  • Prior radiation therapy treatment at the site.
  • Patients on any investigational drug(s) or therapeutic device(s) within 30 days preceding screening.
  • Known history of having Acquired Immunodeficiency Syndrome (AIDS) or HIV.
  • Presence of any condition(s) which seriously compromises the subject's ability to complete this study, or has a known history of poor adherence with medical treatment.
  • Currently taking medications which could affect graft incorporation (supervising physician's discretion).
  • Allergy to gentamicin sulfate and/or streptomycin sulfate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

7 participants in 2 patient groups

Group 1 Control
Other group
Description:
Will receive only traditional craniectomy
Treatment:
Procedure: Craniectomy
Group 2 Treatment dHACM
Experimental group
Description:
Will receive craniectomy, but with the addition of a piece of dHACM placed over any dural defect or dural closure.
Treatment:
Procedure: Craniectomy
Other: dHACM

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems